{{not|磺胺嘧啶}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464391482
| IUPAC_name = Silver [(4-aminophenyl)sulfonyl](pyrimidin-2-yl)azanide
| image = Silver sulfadiazine Silvadene.svg

<!--Clinical data-->
| tradename = Silvadene
| Drugs.com = {{drugs.com|monograph|silver_sulfadiazine}}
| MedlinePlus = a682598
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = B（不建议在妊娠晚期使用）
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx
| routes_of_administration = 外用

<!--Pharmacokinetic data-->
| bioavailability = <1％（银），10％（磺胺嘧啶）<ref name="Stand_Juni_2008">Fachinformation Flammazine Creme, Stand Juni 2008.</ref>
| protein_bound = 高（银）
| metabolism =  
| elimination_half-life =  
| excretion = 2/3 [[肾|肾]]（磺胺嘧啶）

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 22199-08-2
| ATC_prefix = D06
| ATC_suffix = BA01
| ATC_supplemental =  
| PubChem = 441244
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB05245
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 390017
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W46JY43EJR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00433
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 9142
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200766

<!--Chemical data-->
| C=10 | H=9 | Ag=1 | N=4 | O=2 | S=1 
| molecular_weight = 357.14 g/mol
| smiles = [Ag+].O=S(=O)([N-]c1ncccn1)c2ccc(N)cc2
| InChI = 1/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
| InChIKey = UEJSSZHHYBHCEL-UHFFFAOYAS
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UEJSSZHHYBHCEL-UHFFFAOYSA-N
| synonyms = (4-Amino-N-2-pyrimidinylbenzenesulfonamidato-NN,01)-silver, sulfadiazine silver, silver (I) sulfadiazine, 4-amino-N-(2-pyrimidinyl)benzenesulfonamide silver salt, dermazine, geben, silvadene
| melting_point = 285
}}
{{medical}}
'''磺胺嘧啶银'''（[[国际非专利药品名称|INN]]：'''Silver sulfadiazine'''，或silvadene）是一种[[磺胺类药物|磺胺类]]/[[银|银]]盐<ref name="pmid14512929">{{cite journal |author=Fisher NM, Marsh E, Lazova R |title=Scar-localized argyria secondary to silver sulfadiazine cream |journal=J. Am. Acad. Dermatol. |volume=49 |issue=4 |pages=730–2 |date=October 2003 |pmid=14512929 |doi= 10.1067/S0190-9622(02)61574-9|url=http://linkinghub.elsevier.com/retrieve/pii/S0190962202615749}}</ref>[[抗细菌药|抗细菌药]]，用于治疗[[灼伤|烧伤]]的[[外用|外用]]药膏<ref name=Ros2013>{{cite book|last1=Marx|first1=John|last2=Walls|first2=Ron|last3=Hockberger|first3=Robert|title=Rosen's Emergency Medicine - Concepts and Clinical Practice|date=2013|publisher=Elsevier Health Sciences|isbn=1455749877|page=814|url=https://books.google.ca/books?id=uggC0i_jXAsC&pg=PA814|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20160913112905/https://books.google.ca/books?id=uggC0i_jXAsC&pg=PA814|archivedate=2016-09-13}}</ref>，用於二度灼傷和三度灼傷以預防感染。磺胺嘧啶银通常被制成1％的[[霜_(医药)|药膏]]或[[水溶液|水]][[悬浮液|悬浮液]]。品牌有'''Silvadene'''（[[通用商标|通用商标]]）等<ref>http://www.drugs.com/mtm/ssd.html This source names Silvadene, SSD, SSD AF, Thermazene</ref>。研究发现，磺胺嘧啶银可能会增加治疗的时间——如果用这种药物治疗，伤口可能需要更长的时间才能愈合，因此[[科克伦协作网|科克伦系统评价]]的作者不推荐使用<ref>{{cite journal |author=Wasiak J, Cleland H, Campbell F |title=Dressings for superficial and partial thickness burns |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD002106 |year=2008|pmid=18843629 |doi=10.1002/14651858.CD002106.pub3 |quote=The use of silver sulphadiazine (SSD) as a comparator on burn wounds for the full duration of treatment needs to be reconsidered, as a number of studies showed delays in time to wound healing and increased number of dressing applications in patients treated with SSD dressings}}</ref>。

<!-- Side effects and mechanism -->
常見的副作用包括使用部位的瘙癢和疼痛<ref name=AHFS2016/>，其他副作用包括[[白细胞减少症|低白細胞水平]]、[[過敏反應|過敏反應]]、[[銀質沈著症|皮膚藍灰色變色]]、[[溶血反應|紅血球分解]]或[[肝炎|肝炎]]<ref name=AHFS2016/>，對其他[[磺胺類藥物|磺胺類藥物]]過敏的患者應慎用<ref name=AHFS2016/>。接近[[分娩|分娩]]的[[孕婦|孕婦]]也不應該使用<ref name=AHFS2016/>，兩個月以內的兒童也不建議使用磺胺嘧啶銀<ref name=AHFS2016>{{cite web|title=Silver Sulfadiazine|url=https://www.drugs.com/monograph/silver-sulfadiazine.html|website=Drugs.com|publisher=American Society of Health-System Pharmacists|accessdate=30 August 2016|date=June 1, 2008|deadurl=no|archiveurl=https://web.archive.org/web/20160920060256/https://www.drugs.com/monograph/silver-sulfadiazine.html|archivedate=20 September 2016}}</ref>。

<!-- Society and culture -->
磺胺嘧啶銀是在20世紀60年代發現的<ref>{{cite book|last1=Coran|first1=Arnold G.|last2=Caldamone|first2=Anthony|last3=Adzick|first3=N. Scott|last4=Krummel|first4=Thomas M.|last5=Laberge|first5=Jean-Martin|last6=Shamberger|first6=Robert|title=Pediatric Surgery|date=2012|publisher=Elsevier Health Sciences|isbn=032309161X|page=369|edition=7|url=https://books.google.ca/books?id=QpabASTwF_sC&pg=PA369|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20160913123107/https://books.google.ca/books?id=QpabASTwF_sC&pg=PA369|archivedate=2016-09-13}}</ref>。此种化合物被列于[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]内，其中包含基本{{le|医疗卫生制度|Health system}}所需的最重要药物<ref>{{cite web|title=WHO Model List of EssentialMedicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013}}</ref>。它是[[通用名药物|學名藥]]<ref name=AHFS2016/>，在[[發展中國家|發展中國家]]，批發成本在每克0.004到0.072美元之間<ref>{{cite web|title=Silver Sulfadiazine|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=AGS1C&s_year=2014&year=2014&str=1%25&desc=Silver%20Sulfadiazine&pack=new&frm=CREAM&rte=TOP&class_code2=13%2E2%2E&supplement=&class_name=%2813%2E2%2E%29Anti-infective%20medicines%20%28dermatological%29%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=30 August 2016}}{{Dead link|date=2018年7月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>，在美國，一個療程一般花費為25至50美元<ref>{{cite book|last1=Facep|first1=Hamilton MD Faaem Facmt|title=Tarascon Pharmacopoeia 2014 Professional Desk Reference Edition|date=2014|publisher=Jones & Bartlett Publishers|isbn=9781284056716|page=157|url=https://books.google.ca/books?id=F6YdAwAAQBAJ&pg=PA157|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20160913155614/https://books.google.ca/books?id=F6YdAwAAQBAJ&pg=PA157|archivedate=2016-09-13}}</ref>。

== 医疗用途 ==
磺胺嘧啶银兼有磺胺类和银盐的抗菌效果，可抗各种细菌，外用于局部轻度烧伤和大面积擦伤处。

2008年科克伦的系统评价发现，大部分试验的方法存在缺陷，因此其结果没有太大用途<ref name=Was2008>{{cite journal|author=Wasiak J, Cleland H, Campbell F |title=Dressings for superficial and partial thickness burns|journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD002106|year=2008|pmid=18843629|doi=10.1002/14651858.CD002106.pub3 |url= |editor1-last=Wasiak |editor1-first=Jason}}</ref>。另一个2010年的科克伦系统评价得出的结论是，“没有足够的证据能证明，含银敷料或外用药是否能促进伤口愈合，或防止伤口感染”<ref name=Dress2010>{{cite journal|last=Storm-Versloot|first=MN|coauthors=Vos, CG; Ubbink, DT; Vermeulen, H|title=Topical silver for preventing wound infection|journal=Cochrane database of systematic reviews (Online)|date=Mar 17, 2010|issue=3|pages=CD006478|pmid=20238345|doi=10.1002/14651858.CD006478.pub2|editor1-last=Storm-Versloot|editor1-first=Marja N}}</ref>。对其他结果的评价也认为“试验的质量有限”<ref name="systematic1973">{{cite journal |author=Lo SF, Hayter M, Chang CJ, Hu WY, Lee LL |title=A systematic review of silver-releasing dressings in the management of infected chronic wounds |journal=Journal of clinical nursing |volume=17|issue=15|pages=1973–85|year=2008|pmid=18705778 |doi=10.1111/j.1365-2702.2007.02264.x}}</ref>。科克伦的评价增加了人们对愈合时间延长及使用剂量增加的担忧<ref name="Was2008" />。一项2012年的研究也发现，与对照组相比，外用银药物延长了伤口的愈合时间，且没有证据显示其能有效预防伤口感染<ref name=Aziz2012>{{cite journal|last=Aziz|first=Z|coauthors=Abu, SF; Chong, NJ|title=A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds.|journal=Burns : journal of the International Society for Burn Injuries|date=May 2012|volume=38|issue=3|pages=307–18|pmid=22030441|doi=10.1016/j.burns.2011.09.020}}</ref>。

== 不良反应 ==
伤口表面可能会有[[无菌|无菌]]的[[渗出液|渗出液]]（透明液体）。偶有灼热和疼痛感，但只是暂时现象。

约0.1至1％的患者出现[[超敏反应|超敏反应]]，如[[疹|皮疹]]或[[多形红斑|多形红斑]]<ref name="Austria-Codex" />。其他磺胺类药物，包括抗菌剂、[[噻嗪类|噻嗪类]]利尿剂和[[磺酰脲类|磺酰脲类]]抗糖尿病药物也有类似反应，但关于交叉过敏可能性的数据并不一致。银[[离子|离子]]的吸收可导致局部[[银中毒|银中毒]]（皮肤变色）<ref>Chaby, G. et al. (2005): ''Topical silver sulfadiazine-induced acute renal failure''. In: ''Ann Dermatol Venereol.'' '''132'''(11 Pt 1); 891–3; PMID 16327720.</ref><ref>Trop, M. et al. (2006): ''Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient''. In: ''J Trauma.'' '''60'''(3); 648–52; PMID 16531870.</ref><ref>Fisher, NM. et al. (2003): ''Scar-localized argyria secondary to silver sulfadiazine cream''. In: ''J Am Acad Dermatol.'' '''49'''(4); 730–2; PMID 14512929.</ref>，特别是在用[[紫外线|紫外线]]照射过治疗部位后。至今只在过度长期使用、或于严重发炎的烧伤伤口上反复使用的案例中发现了积聚于肾脏、肝脏和[[视网膜|视网膜]]所造成的广泛银中毒。广泛银中毒可能会造成[[间质性肾炎|间质性肾炎]]和[[贫血|贫血]]<ref name="Austria-Codex">{{cite book|title=Austria-Codex|editor=Jasek, W|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2007|edition=62|volume=2|pages=3270–1|isbn=978-3-85200-181-4|language=de}}</ref>。

== 药物相互作用 ==
软膏中用于去除伤口死皮的[[蛋白酶|蛋白酶]]，如[[胰蛋白酶|胰蛋白酶]]和[[梭菌蛋白酶|梭菌蛋白酶]]，如果同时使用，则会被银离子抑制。若磺胺嘧啶银的吸收量足够多，某些药物的作用和副作用则会增强，如[[维生素K拮抗剂|维生素K拮抗剂]]<ref name="Austria-Codex" />。

== 药代动力学 ==
该药物本身难溶于水，且通过皮肤渗透也非常有限。银与蛋白质结合从伤口渗出，且从药物中释放出来的磺胺嘧啶只有小比例（最多10％）被吸收<ref name="Stand_Juni_2008" />。只有当用于大面积烧伤或其他病灶时，机体才可能出现吸收的问题<ref name="Austria-Codex" />。

== 参见 ==
* [[磺胺嘧啶|磺胺嘧啶]]

== 参考 ==
{{reflist}}

{{皮肤病用抗生素和化疗药}}
{{银化合物}}

[[Category:银化合物|Category:银化合物]]
[[Category:磺胺类抗菌药物|Category:磺胺类抗菌药物]]
[[Category:抗菌防腐药|Category:抗菌防腐药]]
[[Category:嘧啶|Category:嘧啶]]